You have 9 free searches left this month | for more free features.

haploidenticalstem cell transplant

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)

Not yet recruiting
  • Acute Leukemia
  • Rifaximin with allogeneic stem cell transplant
  • Allogeneic stem cell transplant
  • (no location specified)
Sep 21, 2023

Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 11, 2023

Intestinal Microbiota in Stem Cell Transplant Transplant

Recruiting
  • Stem Cell Transplant Complications
  • intestinal microbiota
  • Detroit, Michigan
    Henry Ford Health System
Dec 27, 2022

Stem Cell Trial in Houston (Enteral nutrition (EN), Standard care parenteral nutrition (PN))

Recruiting
  • Stem Cell
  • Enteral nutrition (EN)
  • Standard care parenteral nutrition (PN)
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2023

Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T, VRD-based regimen)

Recruiting
  • Plasma Cell Leukemia
  • anti-BCMA CAR-T
  • VRD-based regimen
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Aug 4, 2023

Lung Transplant; Complications Trial in New York (device, diagnostic test, drug)

Not yet recruiting
  • Lung Transplant; Complications
  • Cytomegalovirus T Cell Immunity Panel (CMV-TCIP)
  • +2 more
  • New York, New York
    NYU Langone Health
Jan 24, 2023

Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

Withdrawn
  • Leukemia
  • Donor Enriched Activated Natural Killer Cell Infusion
  • (no location specified)
Dec 20, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Donor Derived Cell Free DNA and Histopathology in Kidney

Not yet recruiting
  • Transplant;Failure,Kidney
  • +2 more
    • (no location specified)
    Apr 11, 2023

    Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

    Not yet recruiting
    • Myeloid Malignancy
    • Acute Myeloid Leukemia
    • Cleveland, Ohio
      University Hospitals Seidman Cancer, Case Comprehensive Cancer C
    Nov 8, 2023

    Development of Liver Dysfunction in Hematopoietic Stem Cell

    Not yet recruiting
    • Hematopoietic Stem Cell Transplant
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 16, 2023

      Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)

      Active, not recruiting
      • Post-transplant Lymphoproliferative Disorder
      • Cleveland, Ohio
        Cleveland Clinic, Case Comprehensive Cancer Center
      Jan 16, 2023

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +11 more
      • Health Promotion and Education
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jul 24, 2023

      Tacrolimus Blood Concentration and Transplant-related Outcomes

      Recruiting
      • Graft Vs Host Disease
      • +2 more
      • TAC C/D ratio
      • Trieste, Italy
        IRCCS Burlo Garofolo
      Oct 6, 2023

      Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

      Active, not recruiting
      • Chronic Granulomatous Disease Transplant
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Cancer Trial in Boston (CARE, Standard Transplant Care)

      Active, not recruiting
      • Cancer
      • CARE
      • Standard Transplant Care
      • Boston, Massachusetts
        Massachusetts General Hospital
      Jan 24, 2023

      Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

      Not yet recruiting
      • Acute Myelogenous Leukemia
      • +17 more
      • Peripheral Blood Stem Cell Transplant
      • +7 more
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Mar 27, 2023

      Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

      Recruiting
      • Acute Myeloid Leukemia
      • +4 more
      • Recombinant Interleukin-7
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 26, 2023

      Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))

      Not yet recruiting
      • Transplantation, Hematopoietic Stem Cell
      • Biological samples (blood and oral fluid)
      • Lyon, France
        Hôpital de la Croix Rousse - service des maladies infectieuses e
      Jul 7, 2023

      Cell Cycle Arrest Proteins for Early Diagnosis of Acute Kidney

      Recruiting
      • Acute Kidney Injury
      • Nephrocheck (AKI score)
      • Milan, Italy
        Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico
      Jun 19, 2023

      Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

      Not yet recruiting
      • Multiple Myeloma
      • (no location specified)
      Oct 25, 2023

      Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

      Recruiting
      • Sickle Cell Disease
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      Longitudinal Study of Cell Free DNA in Lung Transplant

      Completed
      • Lung Transplant Rejection
        • Aurora, Colorado
          University of Colorado, Denver
        Oct 31, 2022

        DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

        Recruiting
        • DOCK8 Deficiency
        • Reduced-intensity hematopoietic stem cell
        • +6 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 27, 2023

        Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)

        Completed
        • Non-Hodgkin's Lymphoma
        • Plasma Cell Myeloma
        • Hematopoietic Cell Transplantation
        • +2 more
        • Philadelphia, Pennsylvania
          Sidney Kimmel Cancer Center at Thomas Jefferson University
        Nov 16, 2022